Research Reveals Global Growth of Secure DevOps
24.3.2021 05:23:00 EET | Business Wire | Press release
New research from Secure Code Warrior ®, the global secure coding company, has revealed an attitudinal shift in the software development industry, with organisations bucking traditional practices for DevOps and Secure DevOps.
The global survey of professional developers and their managers found seven in 10 organisations (70%) recognise the importance of secure coding practices, with results indicating an industry-wide shift from reaction to prevention is underway.
Dr. Matias Madou, Chief Technology Officer and Co-Founder at Secure Code Warrior, said, “We are seeing a fundamental shift in mindsets across the world, as the industry slowly moves from reactive, band-aid solutions rolled out after a breach, to the proactive and human-led practice of writing quality software that is intrinsically free from vulnerabilities right from the very first keystroke.”
“This research shows that ‘secure code’ is becoming synonymous with ‘quality code’ within software development, and security is becoming the responsibility of development teams and leaders—not just AppSec professionals,” he said.
Secure coding seen as ‘reactive’
Reactive practices like using tools on deployed applications and manually reviewing code for vulnerabilities were the top two practices respondents associated with coding securely. However, a proactive shift in mindset was evidenced across the globe, with more than half (55%) of the developers surveyed also recognising secure coding as the active, ongoing practice of writing software protected from vulnerabilities.
Managers and developers are misaligned
Over half (55%) of managers surveyed said secure coding was practised and integrated throughout the entire development process, compared to only 43% of developers. Conversely, 36% of developers consider secure coding during development but not the design phase, as opposed to under one-third (32%) of managers.
Secure code an increasing indicator of success
While those surveyed identified ‘application performance’ and ‘functionality and features’ as the most common success metrics within software development (67% and 62% respectively), almost four in five (79%) respondents said the importance of ‘secure code’ was growing in prominence.
Application security is shifting
Almost half of respondents (46%) said development leads and teams should be responsible for application security rather than AppSec teams (24%). Over eight in 10 (81%) developers surveyed said they were accountable for any vulnerable code produced.
Developers motivated to upskill
‘Increased productivity and efficiency’, ‘curiosity’ and ‘avoiding problems caused by insecure code’ were identified as the leading intrinsic motivators to learn secure coding (20%, 14% and 11% respectively). Despite only 10% of respondents listing career advancement as a personal motivator, four in five (81%) managers were more likely to hire talent with secure coding skills.
More training is needed
91% of managers surveyed said they faced greater than average difficulty when implementing secure coding practices within their organisation, despite the overwhelming majority of respondents (97%) believing they were sufficiently trained. Perhaps, this is because almost nine in 10 (88%) developers surveyed said coding securely was challenging.
Madou added, “With OWASP’s Top 10 software vulnerabilities causing more security breaches over the past two decades than any others, now is the time for businesses to upskill developers to gain the knowledge and skills needed to stamp out insecure code and prevent issues from occurring in the first place.”
“Code is at the heart of everyday interactions, and Secure Code Warrior is focused on championing security-skilled developers who can create amazing, safe software for our connected world.”
To gain early access to the report, ‘Shifting from reaction to prevention: The changing face of application security 2021’, register your interest at scw.buzz/earlyaccess
Methodology
Secure Code Warrior® commissioned Evans Data Corporation, the market intelligence leader within the IT industry, to conduct a global survey of developers and decision-makers actively engaged in software development. In August 2020, 400 respondents were surveyed across North America, India, the United Kingdom, Europe, Australia, New Zealand and South-East Asia.
About Secure Code Warrior
Secure Code Warrior is the developer-chosen solution for growing powerful secure coding skills. By making secure coding a positive and engaging experience for developers as they increase their software security skills, our human-led approach uncovers the secure developer inside every coder, helping development teams ship quality code faster.
Through inspiring a global community of security-conscious developers to embrace a preventative secure coding approach, our mission is to pioneer a people-first solution to security upskilling, stamping out poor coding patterns for good. Learn more at securecodewarrior.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323006113/en/
Contact information
For media enquiries, to access the full report or arrange an interview:
Carly Ryan, Hotwire
E: securecodewarrior@hotwireglobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays1.9.2026 08:00:00 EEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Health Canada has issued Class II Medical Device Licenses (MDL) for the Lumipulse G NfL Blood and the Lumipulse G pTau 217 Plasma assay for use on the fully automated LUMIPULSE® G immunoassay platform in the Canadian market. "The approval of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for clinical use in Canada marks another important step in our mission to expand access to reliable and clinically meaningful blood-based biomarkers for clinicians and patients worldwide," said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “As a pioneer in neurological diagnostics, Fujirebio remains committed to advancing patient care through innovative, fully automated testing solutions." These approvals further strengthen Fujirebio’s comprehensive neurological diagnostics portfolio by broadening access to high-quality biomarker solutions designed to inform clinical decision-making across the
Helical Fusion Named a Final Candidate for Japan’s METI Fusion Power Demonstration Program1.9.2026 05:00:00 EEST | Press release
Helical Fusion Co., Ltd., a fusion energy company developing a Helical Stellarator toward commercially viable fusion power, has been named a final candidate for Japan’s Ministry of Economy, Trade and Industry (METI) program supporting the demonstration of fusion power generation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831991676/en/ Image of Helix HARUKA, Helical Fusion’s Integrated Demo Device(left), and Helix KANATA, Helical Fusion’s Fusion Pilot Plant(right) The program is designed to accelerate fusion power demonstration in the 2030s under Japan’s national energy and fusion strategies. It supports private-sector technology development across multiple fusion approaches, including tokamak, stellarator and laser fusion, with approximately JPY 60 billion in total government support anticipated over the three years through 2028. The amount to be awarded to Helical Fusion will be announced following the formal grant
Strategic Combination of ITC Infotech and Happiest Minds Technologies to Create a Scaled, Future-Ready, AI-First Global Technology Services Enterprise with US$ 1 Billion Revenue by FY28 [1]1.9.2026 00:35:00 EEST | Press release
ITC Infotech (ITCI), a wholly owned subsidiary of ITC Limited and a leading global technology services player, today announced the proposed strategic combination with Happiest Minds Technologies Limited (Happiest Minds) to create a scaled, future-ready, AI-first global technology services enterprise. The ITCI Board approved a proposal to acquire 22.1% equity stake from the promoter of Happiest Minds in two tranches under a Share Purchase Agreement. The transaction would be funded through a Rights Issue by ITC Infotech. ITCI Board has also approved a proposed Scheme of Amalgamation of Happiest Minds with ITCI which will be effected after the share acquisition. Pursuant to the scheme, the shares of ITCI will be listed on the stock exchanges. The proposed transaction has also been endorsed by the Board of Directors of ITC Limited. This strategic combination will synergistically blend ITCI’s AI-led capabilities across Cloud, Data Analytics, PLM, SAP, enterprise transformation, industry-spe
Angel’s Profits Grew Robustly in the First Half of 2026 with Europe and North America Turning Profitable Ahead of Schedule31.8.2026 22:07:00 EEST | Press release
Angelalign Technology Inc. (“Angel” or the “Company”) (6699.HK) (angelaligner.com), the second largest clear aligner supplier by revenue, announced today that its revenue grew 42.9% to US$230.7 million and net profit grew 79.6% to $25.5 million for the six months ending June 30, 2026. Angel’s business in Europe and North America crossed into profitability ahead of plan while the business in Chinese mainland delivered market share gains well above expectations. Doctors and staff in every region report that they are increasingly selecting Angel’s solutions after experiencing more predictable outcomes, especially on complex cases, and embracing the positive culture of the company. Dr. Mark Holt D.D.S., M.S. of Holt Orthodontics in Northern California, states: “We treat over half of our patients with clear aligners and our experience with Angel’s treatment plans and clear aligners has been tremendous.” “Our main focus is to provide great service to and being a rock-solid partner for our cu
BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines31.8.2026 22:00:00 EEST | Press release
BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale. The agreement builds on BeOne's longstanding commitment to patient access and investment in research and scientific innovation. John V. Oyler, Co-Founder, Chairman and CEO, BeOne Medicines, said: “At BeOne, we believe every patient should benefit from innovative cancer therapies. We appreciate the Trump Administration’s commitment to advancing solutions that broaden access and scientific progress for American patients. This agreement reflects our purpose to reach more patients as we expand our U.S. investment in additional research, development, and manufacturing to deliver breakthrough cancer treatments worldwide.” Improved access to oncol
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
